AccuSift provides high-performance antibody pairs for Soluble Suppression of Tumorigenicity 2 (sST2) with exceptional lot-to-lot consistency. Optimized for IVD kit development (Lateral Flow, CLIA, ELISA, POCT), these antibodies offer high affinity and specificity to facilitate rapid detection.

Background:

Soluble Suppression of Tumorigenicity 2 (sST2) is a novel biomarker that reflects inflammation, fibrosis, and myocardial stress simultaneously. It is used for risk stratification, prognosis assessment, and guidance of personalized therapy in patients with acute or chronic heart failure.

Key Characteristics:

Source: Mouse Monoclonal Antibody

Purity: ≥ 90%

Recommended Pairing: (Coating) / (Label)

Storage: Store at ≤ -20°C for long-term stability. Short-term storage at 2-8°C is acceptable. Shipped on ice packs.